ProShare Advisors’s Albany Molecular Research Inc AMRI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-24,659
| Closed | -$535K | – | 1438 |
|
|
2017
Q2 | $535K | Sell |
24,659
-1,744
| -7% | -$37.8K | 0.01% | 939 |
|
|
2017
Q1 | $370K | Sell |
26,403
-6,602
| -20% | -$92.5K | ﹤0.01% | 1144 |
|
|
2016
Q4 | $619K | Buy |
33,005
+2,956
| +10% | +$55.4K | 0.01% | 974 |
|
|
2016
Q3 | $496K | Sell |
30,049
-317
| -1% | -$5.23K | 0.01% | 959 |
|
|
2016
Q2 | $408K | Buy |
30,366
+413
| +1% | +$5.55K | 0.01% | 1055 |
|
|
2016
Q1 | $458K | Sell |
29,953
-2,902
| -9% | -$44.4K | 0.01% | 1038 |
|
|
2015
Q4 | $652K | Buy |
32,855
+2,931
| +10% | +$58.2K | 0.01% | 926 |
|
|
2015
Q3 | $521K | Sell |
29,924
-127
| -0.4% | -$2.21K | 0.01% | 924 |
|
|
2015
Q2 | $608K | Sell |
30,051
-1,424
| -5% | -$28.8K | 0.01% | 1012 |
|
|
2015
Q1 | $554K | Buy |
31,475
+4,312
| +16% | +$75.9K | 0.01% | 1126 |
|
|
2014
Q4 | $442K | Buy |
27,163
+571
| +2% | +$9.29K | 0.01% | 1263 |
|
|
2014
Q3 | $587K | Sell |
26,592
-5,157
| -16% | -$114K | 0.01% | 1311 |
|
|
2014
Q2 | $639K | Sell |
31,749
-15,980
| -33% | -$322K | 0.01% | 1429 |
|
|
2014
Q1 | $887K | Buy |
47,729
+32,071
| +205% | +$596K | 0.01% | 1402 |
|
|
2013
Q4 | $158K | Sell |
15,658
-10,209
| -39% | -$103K | ﹤0.01% | 1274 |
|
|
2013
Q3 | $333K | Buy |
+25,867
| New | +$333K | 0.01% | 1816 |
|